Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
View graph of relations

Main research areas

Understanding the type 1 diabetes pathogenesis; identifying biomarkers for disease prediction, better diagnosis and treatment monitoring. Studies of the role of non-coding RNAs in health and disease biology. Detailed studies of beta-cell biology.

Current research

Identification of biomarkers for type 1 diabetes prediction, diagnosis, progression and treatment response. INNODIA partner (IMI2 project) focusing on translational aspects of beta-cell and immunology research in type 1 diabetes. Lipidomics and metabolomics profiling in pre-diabetic individuals. Is there a role for epigenetics in type 1 diabetes development. Identification of novel non-coding RNAs in type 1 diabetes and inflammatory bowel disease.

Potential conflicts of interest

None

Expertises

Autoimmunity with specific emphasis on type 1 diabetes; genetics; epigenetics; lipidomics; metabolomics; beta-cell biology; immunology; cellular and molecular biology; non-coding RNAs; bioinformatics

ID: 38657836